Pilot Objective To determine whether a rigorous cognitive reablement program could improve symptoms of persons with Alzheimer’s or other dementias that are likely to translate to improved quality of life …
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman talks with Lisa, a woman in her early 70s living with Alzheimer’s. Lisa is a patient of Dr. Bergman at …
Living Well with Alzheimer’s- Lisa’s Story of Getting Back to Herself Read More »
For decades, it was widely accepted that there is no cure for Alzheimer’s and dementia. While this may remain true today, things are rapidly changing in the field of brain …
By Jenny Kemper, Director, Kemper Cognitive Wellness In the office at Kemper Cognitive Wellness, Dr. Bergman will marvel from time to time how much money people are willing to spend …
Published on Cleveland.com, July 2, 2021 By Shirley MacFarland, special to cleveland.com STRONGSVILLE, Ohio — Kemper House Residential Alzheimer’s and Dementia homes have cared for and supported Clevelanders impacted by dementia …
The Kemper House Family’s Focus is Prevention and Effective Treatment for Cognitive Loss Read More »
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman speaks with Dr. Marwan Sabbagh, clinical and research leader at the Cleveland Clinic’s Lou Ruvo Center for Brain Health. He …
Dr. Nate Bergman recently spoke with the folks at Wild Health Podcast. In this conversation, they discussed the difference between Alzheimer’s and dementia, the importance of starting interventions early, and …
Treating Alzheimer’s Disease with Dr. Nate Bergman- Wild Health Podcast Read More »
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman speaks with Doctors Ann Hathaway and Deborah Gordon, the two other physicians who led the ground-breaking clinical trial with Doctors …
People Getting Better- More Trial Results with Dr. Ann Hathaway & Dr. Deborah Gordon Read More »
It’s been 18 years since the last drug was approved for Alzheimer’s, but on Monday, June 7, 2021, the FDA gave “Accelerated Approval” to Biogen’s novel medication, Aducanumab (“Aduhelm”). The …
Aducanumab – Is this the end of Alzheimer’s? Not just yet… Read More »
